Q

uniQure NV
D

QURE

15.740
USD
-0.75
(-4.55%)
مغلق
حجم التداول
65,616
الربح لكل سهم
-4
العائد الربحي
-
P/E
-3
حجم السوق
767,217,024
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ALNY
    ALNY
    -8.630
    (-3.50%)
    237.920 USD
    B
    BLUE
    -0.51500
    (-5.75%)
    8.44000 USD
    C
    CRSP
    -3.490
    (-7.83%)
    41.110 USD
    E
    EDIT
    -0.17500
    (-11.51%)
    1.34500 USD
    GILD
    GILD
    -2.130
    (-2.30%)
    90.630 USD
    MRK
    MRK
    -1.770
    (-1.77%)
    98.300 USD
    N
    NTLA
    -1.110
    (-8.45%)
    12.020 USD
    S
    SGMO
    -0.48000
    (-17.02%)
    2.34000 USD
    S
    SLDB
    -0.42000
    (-9.44%)
    4.03000 USD
    V
    VYGR
    -0.44500
    (-7.13%)
    5.80000 USD
    المزيد
الأخبار

العنوان: uniQure NV

القطاع: Healthcare
الصناعة: Biotechnology
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.